Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Million)
1.2.1. Aptamers Market, by Region, 2019-2027 (USD Million)
1.2.2. Aptamers Market, by Type, 2019-2027 (USD Million)
1.2.3. Aptamers Market, by Technology, 2019-2027 (USD Million)
1.2.4. Aptamers Market, by Application, 2019-2027 (USD Million)
1.2.5. Aptamers Market, by End User, 2019-2027 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Aptamers Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Aptamers Market Dynamics
3.1. Aptamers Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Investments in pharmaceutical R&D
3.1.1.2. Rising prevalence of chronic and rare diseases
3.1.2. Market Restraint
3.1.2.1. Low market acceptance as compared to antibodies
3.1.3. Market Opportunities
Chapter 4. Venture capital funding Global Aptamers Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Aptamers Market, by Type
5.1. Market Snapshot
5.2. Global Aptamers Market by Type, Performance - Potential Analysis
5.3. Global Aptamers Market Estimates & Forecasts by Type 2018-2027 (USD Million)
5.4. Aptamers Market, Sub Segment Analysis
5.4.1. DNA Aptamers
5.4.2. XNA Aptamers
5.4.3. RNA Aptamers
Chapter 6. Global Aptamers Market, by Technology
6.1. Market Snapshot
6.2. Global Aptamers Market by Technology, Performance - Potential Analysis
6.3. Global Aptamers Market Estimates & Forecasts by Technology 2018-2027 (USD Million)
6.4. Aptamers Market, Sub Segment Analysis
6.4.1. SELEX
6.4.2. Others
Chapter 7. Global Aptamers Market, by Application
7.1. Market Snapshot
7.2. Global Aptamers Market by Application, Performance - Potential Analysis
7.3. Global Aptamers Market Estimates & Forecasts by Application 2018-2027 (USD Million)
7.4. Aptamers Market, Sub Segment Analysis
7.4.1. Therapeutics Development
7.4.2. Research & Development
7.4.3. Diagnostic
7.4.4. Others
Chapter 8. Global Aptamers Market, by End User
8.1. Market Snapshot
8.2. Global Aptamers Market by End User, Performance - Potential Analysis
8.3. Global Aptamers Market Estimates & Forecasts by End User 2018-2027 (USD Million)
8.4. Aptamers Market, Sub Segment Analysis
8.4.1. Pharmaceutical & Biotechnology Companies
8.4.2. Academic & Government Research Institutes
8.4.3. CROs
8.4.4. Others
Chapter 9. Global Aptamers Market, Regional Analysis
9.1. Aptamers Market, Regional Market Snapshot
9.2. North America Aptamers Market
9.2.1. U.S. Aptamers Market
9.2.1.1. Type breakdown estimates & forecasts, 2018-2027
9.2.1.2. Technology breakdown estimates & forecasts, 2018-2027
9.2.1.3. Application breakdown estimates & forecasts, 2018-2027
9.2.1.4. End User breakdown estimates & forecasts, 2018-2027
9.2.2. Canada Aptamers Market
9.3. Europe Aptamers Market Snapshot
9.3.1. U.K. Aptamers Market
9.3.2. Germany Aptamers Market
9.3.3. France Aptamers Market
9.3.4. Spain Aptamers Market
9.3.5. Italy Aptamers Market
9.3.6. Rest of Europe Aptamers Market
9.4. Asia-Pacific Aptamers Market Snapshot
9.4.1. China Aptamers Market
9.4.2. India Aptamers Market
9.4.3. Japan Aptamers Market
9.4.4. Australia Aptamers Market
9.4.5. South Korea Aptamers Market
9.4.6. Rest of Asia Pacific Aptamers Market
9.5. Latin America Aptamers Market Snapshot
9.5.1. Brazil Aptamers Market
9.5.2. Mexico Aptamers Market
9.6. Rest of The World Aptamers Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Aptamer Group
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Raptamer Discovery Group
10.2.3. SomaLogic Inc.
10.2.4. Aptagen, LLC
10.2.5. Maravai Lifesciences
10.2.6. Kaneka Corporation
10.2.7. NeoVentures Biotechnology Inc.
10.2.8. Aptus Biotech
10.2.9. Base Pair Biotechnologies
10.2.10. AMSBIO
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption